Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced ...
Virax Biolabs enters agreement with Tebubio to expand distribution of ImmuneSelect across EU, Norway & Switzerland: London Wednesday, December 11, 2024, 17:00 Hrs [IST] Virax Biol ...
Historically, inflammation against self was considered autoimmune, a concept that stems back to the seminal observations by Ehrlich, who described serum factors now known to be autoantibodies produced ...
Despite promising Phase II data, there was no difference in overall survival between the patients who received Canvaxin and the patients who received placebo in the randomized Phase III trial of ...
Dec. 6, 2024 — A researcher has uncovered evidence of intestinal parasites in a 500-year-old latrine from Bruges, Belgium, and while the finding may induce queasiness in some, it is expected to ...